PRMT5 regulates antigen presentation by controlling NLRC5 expression, which regulates the expression of MHC class I genes, and the inhibition of PRMT5 expression leads to the increased expression of surface MHC class I and tumor cell recognition [18]. Here, NLRC5 is linked to neoplasm.